ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
105,718.83
-0.42%
S&P 500
6,049.24
0.88%
Dow Jones
44,025.81
1.24%
US Dollar vs Yen
155.7935
0.01%
Brent Oil
78.64
-0.14%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE

  6. Fusion Antibodies Plc (FAB) 銘柄情報

Fusion Antibodies Plc

Fusion Antibodies Plc (FAB)

First Trust Multi Cap Value AlphaDEX Fund
9.15
0.05
(0.55%)
終了 1月22日 1:30AM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
9.15
買値
8.80
売値
9.50
出来高
661,393
9.10 日の範囲 9.25
2.90 52 週間の範囲 11.75
時価総額
8.726M
前日終値
9.10
始値
9.10
時刻
4
@
9.29
(O)
最終取引時間
財務取引量
62,832p
VWAP
9.50
平均取引量 (3 か月)
1,576,970
発行済株式数
95,365,564
配当利回り
-
PER
-3.93
1 株当たり利益 (EPS)
-0.02
歳入
1.14M
純利益
-2.23M

Fusion Antibodies Plc について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.fusionantibodies.com
本社
Belfast, Gbr
設立
-
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker FAB. The last closing price for Fusion Antibodies was 9.10p. Over the last year, Fusion Antibodies shares have traded in a share price range of 2.90p to 11.75p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £8.68 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -3.93.

FAB 最新ニュース

その他のニュース

Fusion Antibodies receives approval of grant funding application

Fusion Antibodies PLC on Wednesday announced the approval of a grant funding application to The Northern Ireland Prec ...

2024年12月4日
Alliance News

Fusion Antibodies PLC Approval of Grant Funding Application

Fusion Antibodies PLC 04 December 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

2024年12月4日
RNS Regulatory News

Fusion Antibodies interim loss narrows as revenue more than doubles

Fusion Antibodies PLC on Tuesday said its loss narrowed in the first half of its current financial year, as revenue m ...

2024年11月19日
Alliance News

Fusion Antibodies PLC Half-year Report

Fusion Antibodies PLC 19 November 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

2024年11月19日
RNS Regulatory News

Fusion Antibodies PLC Director/PDMR Shareholding

Fusion Antibodies PLC 16 October 2024   16 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Director/PDMR Shareholding   Fusion Antibodies plc (AIM: FAB), specialists in...

2024年10月16日
RNS Regulatory News

Fusion Antibodies PLC Issue of shares to non-executive directors

Fusion Antibodies PLC 16 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

2024年10月16日
RNS Regulatory News

IN BRIEF: Fusion Antibodies expects interim revenue to double

PLC - Belfast-based contract researcher that provides discovery, design and optimisation services for therapeutic ant ...

2024年10月8日
Alliance News

Fusion Antibodies PLC Result of AGM

Fusion Antibodies PLC 08 October 2024     Fusion Antibodies plc ("Fusion" or the "Company")   Result of AGM   Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery...

2024年10月8日
RNS Regulatory News

Fusion Antibodies PLC AGM statement and trading update

Fusion Antibodies PLC 08 October 2024   The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...

2024年10月8日
RNS Regulatory News

Fusion Antibodies PLC Block admission six monthly return

Fusion Antibodies PLC 02 October 2024   2 October 2024    Fusion Antibodies plc ("Fusion" or the "Company")   Block admission six monthly return   Fusion Antibodies plc (AIM: FAB), specialists...

2024年10月2日
RNS Regulatory News
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.1-1.081081081089.259.257.757780498.45060409DE
42.1530.7142857143711.756.8218622039.14518859DE
124.9115.2941176474.2511.753.9515769706.94543811DE
266190.4761904763.1511.752.913516925.53022989DE
521.926.20689655177.2511.752.912668214.73925073DE
156-100.85-91.68181818181101102.97507916.18576386DE
260-83.35-90.108108108192.52502.946544910.80632515DE

FAB - Frequently Asked Questions (FAQ)

What is the current Fusion Antibodies share price?
The current share price of Fusion Antibodies is 9.15p
How many Fusion Antibodies shares are in issue?
Fusion Antibodies has 95,365,564 shares in issue
What is the market cap of Fusion Antibodies?
The market capitalisation of Fusion Antibodies is GBP 8.68M
What is the 1 year trading range for Fusion Antibodies share price?
Fusion Antibodies has traded in the range of 2.90p to 11.75p during the past year
What is the PE ratio of Fusion Antibodies?
The price to earnings ratio of Fusion Antibodies is -3.93
What is the cash to sales ratio of Fusion Antibodies?
The cash to sales ratio of Fusion Antibodies is 7.69
What is the reporting currency for Fusion Antibodies?
Fusion Antibodies reports financial results in GBP
What is the latest annual turnover for Fusion Antibodies?
The latest annual turnover of Fusion Antibodies is GBP 1.14M
What is the latest annual profit for Fusion Antibodies?
The latest annual profit of Fusion Antibodies is GBP -2.23M
What is the registered address of Fusion Antibodies?
The registered address for Fusion Antibodies is 1 SPRINGBANK ROAD, SPRINGBANK INDUSTRIAL ESTATE, DUNMURRY, BELFAST, BT17 0QL
What is the Fusion Antibodies website address?
The website address for Fusion Antibodies is www.fusionantibodies.com
Which industry sector does Fusion Antibodies operate in?
Fusion Antibodies operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
BSFABsf Enterprise Plc
3.375p
(35.00%)
13.75M
STBSecure Trust Bank Plc
465.00p
(33.62%)
929.66k
TIATialis Essential It Plc
26.50p
(23.26%)
105.62k
CBGClose Brothers Group Plc
298.40p
(21.90%)
4.6M
NTQEnteq Technologies Plc
1.25p
(-23.31%)
3.22M
BANKFiinu Plc
8.625p
(-15.85%)
21.19M
TIRTiger Royalties And Investments Plc
0.135p
(-15.63%)
75.44M
RCGHRc365 Holding Plc
1.80p
(-14.29%)
1.7M
INDIIndus Gas Limited
7.80p
(-13.33%)
214.66k
NTVONativo Resources Plc
0.0021p
(0.00%)
2.71B
PREMPremier African Minerals Limited
0.026p
(-3.70%)
623.1M
NTOGNostra Terra Oil And Gas Company Plc
0.043p
(36.51%)
524.2M
TRPTower Resources Plc
0.0305p
(0.00%)
504.66M
SYMESupply@me Capital Plc
0.003p
(-3.23%)
469.16M

議論

フィード全体を表示

最近閲覧した銘柄

LSE
FAB
Fusion Antibodies
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有